Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Case-Based Guide to Clinical EndocrinologyDopamine Agonist-Induced Impulse Control Disorders

A Case-Based Guide to Clinical Endocrinology: Dopamine Agonist-Induced Impulse Control Disorders [Dopamine agonists (DA) are widely used in the management of prolactinomas, as they are largely effective in controlling tumor secretion and growth. Dopamine agonist administration is safe with only minor adverse effects reported in most cases (e.g., gastrointestinal symptoms and postural hypotension). Neuropsychiatric side effects such as impulse control disorders (ICD; e.g., pathological gambling, compulsive shopping, and hypersexuality) have been described in neurological patients treated for Parkinson’s disease and restless leg syndrome with high doses of DA. Accumulating evidence suggests that ICD in patients with prolactinomas treated with DA are not as rare as previously thought.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Case-Based Guide to Clinical EndocrinologyDopamine Agonist-Induced Impulse Control Disorders

Download PDF
10 pages

Loading next page...
 
/lp/springer-journals/a-case-based-guide-to-clinical-endocrinology-dopamine-agonist-induced-Gs8G9yRv0j
Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
ISBN
978-3-030-84366-3
Pages
43 –53
DOI
10.1007/978-3-030-84367-0_4
Publisher site
See Chapter on Publisher Site

Abstract

[Dopamine agonists (DA) are widely used in the management of prolactinomas, as they are largely effective in controlling tumor secretion and growth. Dopamine agonist administration is safe with only minor adverse effects reported in most cases (e.g., gastrointestinal symptoms and postural hypotension). Neuropsychiatric side effects such as impulse control disorders (ICD; e.g., pathological gambling, compulsive shopping, and hypersexuality) have been described in neurological patients treated for Parkinson’s disease and restless leg syndrome with high doses of DA. Accumulating evidence suggests that ICD in patients with prolactinomas treated with DA are not as rare as previously thought.]

Published: Jan 4, 2022

Keywords: Dopamine agonist; Treatment; Prolactinoma; Adverse effect; Impulse control disorder; Depression

There are no references for this article.